当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第10期
编号:13344947
奥马珠单抗治疗难治性变应性哮喘效果的Meta分析(4)
http://www.100md.com 2019年4月5日 《中国医药导报》 2019年第10期
     [7] Finn A,Gross G,Bavel JV,et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma [J]. J Allergy Clin Immunol,2003,111(2):278-284.

    [8] Humbert M,Beasley R,Ayres J,et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy(GINA 2002 step 4 treatment ):INNOVATE [J]. Allergy ......
上一页1 2 3 4 5下一页

您现在查看是摘要页,全文长 2657 字符